ThyGenX and ThyraMIR (Interpace Diagnostics)
HAYES, Inc
Record ID 32018000085
English
Authors' recommendations:
Imaging studies with ultrasound, combined with cytological examination of thyroid biopsies collected by fine-needle aspiration (FNA), can aid in distinguishing between benign and cancerous thyroid nodules; however, from 10% to 25% of biopsies are indeterminate, meaning that a diagnosis of cancerous versus benign cannot be made on the basis of cytological examination. Molecular profiling can be used to identify molecular alterations that are specific to thyroid malignancy in order to distinguish malignant from benign thyroid cytology and, thus, molecular profiling of FNA samples of indeterminate status could aid in distinguishing between benign and cancerous thyroid nodules. This report examines the ThyGenX and ThyraMIR tests.
Details
Project Status:
Completed
Year Published:
2017
URL for published report:
The report may be purchased from:
http://www.hayesinc.com/hayes/crd/?crd=74966
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Biopsy, Fine-Needle
- Cytodiagnosis
- Humans
- Thyroid Neoplasms
- Thyroid Nodule
- Ultrasonography
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.